Back to Search Start Over

Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's disease.

Authors :
Carreño M
Martí MJ
Aldecoa I
Painous C
Conde E
Valldeoriola F
Valls-Solé J
Bargalló N
Gil F
Manzanares I
Setoain X
Donaire A
Muñoz E
Roldán P
Boget T
Pintor L
Bailles E
Rumià J
Source :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2019 Jan; Vol. 90 (1), pp. 108-110. Date of Electronic Publication: 2018 Jul 09.
Publication Year :
2019

Abstract

Objective: To describe an adult patient with Rasmussen's disease with focal dystonia as the most disabling symptom and the good response to unilateral globus pallidus internus (GPi) deep brain stimulation (DBS).<br />Methods: Retrospective review of clinical records and diagnostic tests.<br />Results: The patient had displayedmild focal seizures with sensory and motor symptoms on the left arm and hemiface since the age of 22. Ten years later she experienced abrupt onset of focal left dystonia involving mainly the leg. Brain MRI showed progressive right hemisphere atrophy, and   <superscript>18</superscript> fluorodeoxyglucose-positron emission tomography ( <superscript>18</superscript> FDG-PET) showed right hypometabolism mainly over the frontal and insular regions. Brain biopsy confirmed chronic encephalitis. The dystonia became very severe and made walking extremely difficult. Different treatments including dopaminergic, anticholinergic, immunomodulatory drugs and botulinum toxin were ineffective. Finally the patient was treated with unilateral GPi DBS. Shortly after the onset of the stimulation, the dystonia started to improve. Parameters have been adjusted, and 18 months after surgery the patient is able to walk and run unaided, although a mild left leg dystonia persists.<br />Conclusion: Rasmussen's disease may be difficult to diagnose in adult patients. Associated movement disorders may be more disabling than seizures. Focal dystonia may be treated successfully with DBS.<br />Competing Interests: Competing interests: MC has received honoraria from Eisai, UCB Pharma, Esteve, Bial pharmaceuticals and Medtronic for teaching activities and advisory boards. JR has received honorarium from Medtronic for teaching activities.<br /> (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1468-330X
Volume :
90
Issue :
1
Database :
MEDLINE
Journal :
Journal of neurology, neurosurgery, and psychiatry
Publication Type :
Academic Journal
Accession number :
29986904
Full Text :
https://doi.org/10.1136/jnnp-2018-318029